BGAM
MJN

Boussard & Gavaudan Asset Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Boussard & Gavaudan Asset Management’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-638,124
Closed -$59.4M – 97
2014
Q2 		$59.4M Buy
638,124
+108,212
+20% +$9.46M 29.67% 2
2014
Q1 		$44M Buy
+529,912
New +$43M 27.1% 2

Other funds holding MJN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Boussard & Gavaudan Asset Management's MJN Position: Q3 2014 in Review

Boussard & Gavaudan Asset Management sold out of Mead Johnson Nutrition Company (MJN) in Q3 2014, closing a stake of 638,124 shares — an estimated $59.4M sold.

Boussard & Gavaudan Asset Management first reported a position in MJN in Q1 2014 and held it in 2 quarters. The position peaked at $59.4M in Q2 2014. 524 funds tracked by Wall St. Rank hold MJN as of Q3 2014.

  • Boussard & Gavaudan Asset Management reported no remaining Mead Johnson Nutrition Company position as of Q3 2014 after selling out during the quarter.
  • Boussard & Gavaudan Asset Management sold 638,124 Mead Johnson Nutrition Company shares in Q3 2014, an estimated $59.4M.
  • Boussard & Gavaudan Asset Management first reported a position in Mead Johnson Nutrition Company in Q1 2014 and held it in 2 quarters.
  • Boussard & Gavaudan Asset Management's Mead Johnson Nutrition Company position peaked at $59.4M in Q2 2014.
  • 524 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q3 2014.

Based on Boussard & Gavaudan Asset Management's 13F filing for Q3 2014.